ABSTRACT
INTRODUCTION
Jaundice is the most common clinical symptom and sign in neonatal period, arising from either overproduction or under secretion of bilirubin. Only a small proportion of babies require investigation as to find a cause of jaundice. Prolonged jaundice can be defined as visibly detectable hyperbilirubinaemia beyond 2 weeks of age in term infant (1) . The majority of healthy term infants with prolonged jaundice has unconjugated hyperbilirubinaemia and will be breast feeding. Since breast milk jaundice being a diagnosis of exclusion it is important to exclude other potentially dangerous causes of prolonged jaundice in these babies including that of biliary atresia (2) .Purpose of Prolonged jaundice screen is to, facilitate early investigation and management of Conjugated jaundice, avoid Intraventricular hemorrhage(due to vitamin K deficiency), Liver failure and associated long-term morbidity due to biliary atresia and avoid bilirubin encephalopathy in missed cases of Haemolytic Jaundice.
The present study was undertaken to evaluate our clinical practice and usefulness of unit protocol for prolonged jaundice screen in well, term babies. All the babies had Stage 1 investigation for prolonged jaundice screen as per unit protocol (Figure 1 ). Data was analysed using simple statistical methods such as Z-test for proportions and percentage calculation.
MATERIALS AND METHODS

RESULTS
The following observations were made from the present study. Figure 1 shows the list of investigations done on babies referred for prolonged jaundice screen. All the babies were examined by pediatric senior house officer who records relevant history and examination findings. All the babies had basic investigations (Stage 1) and then depending on examination findings and initial results further investigations were considered in few babies. Table 1 shows patient details such as gestation at birth, sex, source of referral, method of feeding and condition of baby at the time of referral. Most of the babies were breast fed, term healthy babies without other clinical concerns mostly referred by community team around 3 weeks of life. Table 2 shows summary of investigations, diagnosis and clinical yield of the Screen. 14 babies in present study with unconjugated hyperbilirubinaemia were exclusively breastfed, who otherwise remained well and kept growing had the diagnosis of breast milk jaundice. 17 babies had no diagnosis but remained healthy and thriving (Negative Screen). These 2 groups together constitutes 85% of study population andall these 31 babies were followed up in the out patient clinic until they turned 5 to 6 wks old by which jaundice resolved uneventfully. One baby with conjugated bilirubin just above 20 micromoles/L(1.2mg/dl) remained healthy without further interventions.3 babies had mild hemolytic jaundice one of this was due to ABO incompatibility, started on folic acid supplements and finally discharged from clinic once the hemoglobin was stable and had no evidence of on going haemolysis. 2 other babies who had Stage 3 investigations for Unconjugated Jaundice turned out to be G6PD deficient and were referred to further care to the specialist centre. Baby with UTI was treated in accordance with unit protocol on management of UTI. One baby though clinically looked yellow was otherwise healthy with total bilirubin level of 49 micromoles/L (2.9mg/dl) and hence discharged home with diagnosis of physiological jaundice. Figure 2 shows agreed guidelines for management of well term babies, who remain jaundiced at 14 days of life. The proposed management mainly aims to spot the babies with prolonged jaundice at community level by paramedical person such as community midwife who then refer the baby to hospital specialist such as paediatrician who then divides the babies into conjugated and unconjugated group with an aims to investigates further to rule out serious underlying causes such as biliary atresia, missed cases of haemolytic jaundice and rare metabolic disorders affecting liver which can prove fatal to babies if not identified and addressed in time. The above said aims are met in our study as explained in paragraph 3 and hence we proposed above said management guidelines.
Prolonged Jaundice Screen in Healthy Term Babies
DISCUSSION
Jaundice persists beyond 14days in 15-40% breastfed normal newborns (3, 4) . By 10 days of age 90% neonates will have bilirubin concentration <150 micromoles/L. If the total bilirubin concentration is persistently >50 micromoles/L after 14 days or if conjugated bilirubin >20 micromoles/L, then a cause should be sought. Early supportive management of babies with conjugated jaundice of unknown etiology which resolves on its own as babies grow older is very important as these babies are at risk of death due to intracranial hemorrhage (IVH) as they are prone to vitamin K deficiency. One of the important aims of prolonged jaundice screen is to identify a baby with biliary atresia before the age of 6 weeks (5, 6, 7).
Present study was done keeping these principles in mind. The prolonged jaundice screen proved very useful in our study not only by establishing the cause but also to reassure parents as babies with negative screen remained healthy and thriving as noted by our out patient clinic follow up visits. Based on these findings and current available evidence we proposed the guidelines for management of healthy term babies jaundiced at 14 days (1, 2, 5-8). Our guidelines give due importance to good history, examination by a member of pediatric team and investigating in a stage wise manner as directed by tailoring need of an individual baby.
Prolonged jaundice screen in healthy term babies is a useful tool to reassure a parent and clinician, as both positive and negative screen results are equally helpful. Positive screen helps to address the underlying issue urgently whereas negative screen rules out serious underlying causes including that of biliary atresia and support the diagnosis of breast milk jaundice in breastfed babies.
